Published in
American Society of Hematology, Blood Advances, 6(1), p. 357-366, 2017
DOI: 10.1182/bloodadvances.2016001784
Links
Tools
The clinical spectrum of Erdheim-Chester disease: an observational cohort study
Journal article published in 2017 by
Juvianee I. Estrada-Veras 
,
Kevin J. O’Brien,
Louisa C. Boyd ,
Rahul H. Dave ,
Benjamin H. Durham ,
Liqiang Xi,
Ashkan A. Malayeri,
Marcus Y. Chen ,
Pamela J. Gardner,
Jhonell R. Alvarado Enriquez,
Nikeith Shah,
Omar Abdel-Wahab ,
Bernadette R. Gochuico,
Mark Raffeld,
Elaine S. Jaffe
and other authors.
,
Kevin J. O’Brien,
Louisa C. Boyd ,
Rahul H. Dave ,
Benjamin H. Durham ,
Liqiang Xi,
Ashkan A. Malayeri,
Marcus Y. Chen ,
Pamela J. Gardner,
Jhonell R. Alvarado Enriquez,
Nikeith Shah,
Omar Abdel-Wahab ,
Bernadette R. Gochuico,
Mark Raffeld,
Elaine S. Jaffe
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key Points ECD varies in terms of age of onset, clinical presentation, manifestations, organ involvement, disease severity, and survival. ECD is a neoplasm and should be adopted by the field of hematology-oncology following the World Health Organization reclassification.